![Baxter Phillips](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Baxter Phillips
Presidente presso
Altemia & Co. LLC
Profilo
Baxter F.
Phillips is currently an Independent Director at Cambridge Allergy Ltd. since 2018 and President of Altemia & Co. LLC.
Formerly, Mr. Phillips was Chief Operating Officer & Director at Lobe Sciences Ltd. from 2023 to 2024, President & Chief Executive Officer at Neurogastrx, Inc. from 2015 to 2017, Chief Business Officer at AmpliPhi Biosciences Corp.
from 2014 to 2015, and Head-Investor Relations at Osteologix Holdings Plc from 2010 to 2011.
Education includes an undergraduate degree from Hampden-Sydney College and an MBA from Mason School of Business of The College of William & Mary.
Posizioni attive di Baxter Phillips
| Società | Posizione | Inizio |
|---|---|---|
Cambridge Allergy Ltd.
 Cambridge Allergy Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines for food allergies | Direttore/Membro del Consiglio | 16/10/2018 |
Altemia & Co. LLC
 Altemia & Co. LLC Pharmaceuticals: OtherHealth Technology Operates as a medical food company | Presidente | - |
Precedenti posizioni note di Baxter Phillips
| Società | Posizione | Fine |
|---|---|---|
| LOBE SCIENCES LTD. | Direttore operativo | 12/08/2024 |
Neurogastrx, Inc.
 Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Amministratore Delegato | 01/10/2017 |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Contatto Relazioni con gli Investitori | 27/05/2015 |
| OSTEOLOGIX HOLDINGS PLC | Public Communications Contact | 01/08/2011 |
Formazione di Baxter Phillips
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
20
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Health Technology |
Hampden-Sydney College
 Hampden-Sydney College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Osteologix Holdings Plc
 Osteologix Holdings Plc Pharmaceuticals: OtherHealth Technology Operates as an investment holding company with interest in development of pharmaceuticals | Health Technology |
Mason School of Business of The College of William & Mary
 Mason School of Business of The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cambridge Allergy Ltd.
Cambridge Allergy Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines for food allergies | Health Technology |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Health Technology |
Lobe Sciences Ltd.
 Lobe Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries develops patented drug candidates to treat chronic cluster headache | Health Technology |
Altemia & Co. LLC
Altemia & Co. LLC Pharmaceuticals: OtherHealth Technology Operates as a medical food company | Health Technology |
